Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with A
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q1 2024 | ASPARTAME | ORAL | CAPSULE | 0.80 mg | 3mg | Deletion | |
| Q4 2023 | ANHYDROUS TRISODIUM CITRATE | NASAL | SPRAY | 2.54 mg/ 0.20 ml | MDE Replacement | ||
| Q1 2024 | ANHYDROUS TRISODIUM CITRATE | NASAL | SPRAY | 8mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024